Quantcast
Home / Verdicts & Settlements / Shareholder uprising against PPD merger quelled by settlement (access required)

Shareholder uprising against PPD merger quelled by settlement (access required)

But not all investors are happy with agreement which allows $3.9 billion deal to proceed

Despite objections from one institutional shareholder, the North Carolina Business Court has approved the settlement of a class action against Wilmington-based clinical research company Pharmaceutical Product Development Inc. and two private equity firms.

Leave a Reply

Your email address will not be published. Required fields are marked *

*